Call for Abstract

11th Global Care Conference on Breast Cancer Therapies and Nursing Care, will be organized around the theme “Novel Discoveries for Diagnosis and Prevention of Breast Cancer”

Breast Cancer Care 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Breast Cancer Care 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

The stage of a cancer describes how much cancer is in the body. It helps determine how serious the cancer is and how best to treat it. Doctors also use a cancer's stage when talking about survival statistics. The earliest stage breast cancers are stage 0. It then ranges from stage I through IV. As a rule, the lower the number, the less the cancer has spread. A higher number, such as stage IV, means cancer has spread more. And within a stage, an earlier letter means a lower stage.


  • Track 1-1Stage I Breast Cancer
  • Track 1-2Invasive Breast Cancer
  • Track 1-3Recurrent breast cancer
  • Track 1-4Metastatic Breast Cancer
  • Track 1-5Locally advanced Breast Cancer
  • Track 1-6Recurrent Breast Cancer

Radiation therapy also called radiotherapy uses high-energy rays to kill cancer cells. It affects cells only in the part of the body that is treated with the radiation. Breast cancer radiation therapy may be used to destroy any remaining mutated cells that remain in the breast or armpit area after surgery. There are two main kinds of radiation therapy that may be considered:
External Breast Cancer Radiation (Traditional cancer-killing rays delivered by a large machine)
Internal Breast Cancer Radiation (Newer treatments that inject radioactive cancer-killing treatments only in the affected area)

  • Track 2-1Branchy Therapy
  • Track 2-2Breast reconstruction
  • Track 2-3Intra Operative Radiation Therapy
  • Track 2-4Breast Conserving Surgery

Cancer stem cells are rare immortal cells within a tumor that can both self-renew by dividing and give rise to many cell types that constitute the tumor, and can therefore form tumors. Such cells have been found in various types of human tumors and might be attractive targets for cancer treatment. Since the introduction of the "cancer stem cell" theory, significant developments have been made in the understanding of cancer and the heterogenic structure of tumors. Although uncertainties about breast cancer stem cells exist, many of researchers believe that cancer stem cells should be considered as possible therapeutic targets.


  • Track 3-1Biological markers
  • Track 3-2Breast Cancer Stem Cell Markers
  • Track 3-3Neoplastic stem cells
  • Track 3-4Signaling Pathways of Breast Cancer Stem Cells
  • Track 3-5Microenvironment and Breast Cancer Stem Cells

Clinical trials are research studies that test new treatments to see how well they work. They are an essential part of our quest to find better ways to prevent, treat, and cure cancer. Almost every cancer treatment patients receive today is the result of a clinical trial. There are several kinds of clinical trials for cancer. Some look at new therapies that may be able to help treat or potentially cure the disease. Others study therapies to see whether they produce fewer side effects than what’s currently used to treat the disease. Still others may focus on improving quality of life for people who have already had cancer treatment or are living with cancer.

The genetic variation can cause Breast Cancer hereditary, new therapeutics innovations are incorporated. New targeted drugs can rectify the genetic cause says research. The rest of the therapeutics and treatment methods are widely in practice. New Innovations and researches are discussed in the session. We welcome researches under genetics of breast cancer, therapeutics and new methods and related topics.


  • Track 5-1Genes Associated with Breast Cancer
  • Track 5-2Inheritance Pattern of Breast Cancer
  • Track 5-3Impact of Genetic Mutation and Changes
  • Track 5-4Techniques to Lower the side effects of Radiotherapy
  • Track 5-5Genotypic Mapping- Basic Understanding
  • Track 5-6Targeted Treatments
  • Track 5-7Molecular Cancer Therapeutics
  • Track 5-8OCT ( Optical Coherence Tomography) a stepping stone
  • Track 5-9Routine Cancer Genotyping

Chemotherapy treatment uses medicine to weaken and destroy cancer cells in the body, including cells at the original cancer site and any cancer cells that may have spread to another part of the body. Chemotherapy affects the whole body by going through the bloodstream. There are quite a few chemotherapy medicines. In many cases, a combination of two or more medicines will be used as chemotherapy treatment for breast cancer.

Metastatic breast cancer (also called stage IV) is breast cancer that has spread to another part of the body, most commonly the liver, brain, bones, or lungs. Cancer cells can break away from the original tumor in the breast and travel to other parts of the body through the bloodstream or the lymphatic system, which is a large network of nodes and vessels that works to remove bacteria, viruses, and cellular waste products. Breast cancer can come back in another part of the body months or years after the original diagnosis and treatment. Nearly 30% of women diagnosed with early-stage breast cancer will develop metastatic disease.

  • Track 7-1Radiation for Metastatic Breast Cancer
  • Track 7-2Breast Imaging with Shearware Elastography

Psychological changes in general population of people with cancer may be accompanied by biological changes in their brains. Analysis of brain activity should be included in future research on survival of patients with cancer to provide the missing link between mind, brain, and body.

Oncology rehabilitation includes a wide range of therapies designed to help you build strength and endurance, regain independence, reduce stress and maintain the energy to participate in daily activities. Breast cancer and its treatment may affect your physical functioning and energy. For instance, many breast cancer treatments decrease estrogen in the body, which may decrease bone density. Exercise may be used to promote bone density and help lower the risk of breast cancer recurrence. Exercise may also help you manage treatment-related fatigue, especially during radiation treatments.

  • Track 9-1Physical therapy
  • Track 9-2Occupational therapy
  • Track 9-3Speech and language pathology
  • Track 9-4Manual therapy
  • Track 9-5Auriculotherapy
  • Track 9-6Lymphedema prevention and treatment

Breast cancer is the most common type of cancer among women in the United States. Early detection is key in the treatment of breast cancer. There are steps you can take to detect breast cancer early when it is most treatable. The most important screening test for breast cancer is the mammogram. A mammogram is an X-ray of the breast. It can detect breast cancer up to two years before the tumor can be felt by you or your doctor. Women age 40 - 45 or older who are at average risk of breast cancer should have a mammogram once a year. Women at high risk should have yearly mammograms along with an MRI starting at age 30.

  • Track 10-1Breast Cancer Reports Case Studies
  • Track 10-2Breast Cancer Pathology
  • Track 10-3Breast Pathology Nursing

Breast cancer is the top cancer in women both in the developed and the developing world. The incidence of breast cancer is increasing in the developing world due to increase life expectancy, increase urbanization and adoption of western lifestyles. Although some risk reduction might be achieved with prevention, these strategies cannot eliminate the majority of breast cancers that develop in low- and middle-income countries where breast cancer is diagnosed in very late stages. Therefore, early detection in order to improve breast cancer outcome and survival remains the cornerstone of breast cancer control.

  • Track 11-1Breast cancer burden
  • Track 11-2Breast cancer risk factors
  • Track 11-3Breast cancer control

Plastic specialists routinely submit breast capsulectomy surgical examples for pathologic assessment. Be that as it may, clinically noteworthy discoveries are once in a while recognized. With an end goal to diminish social insurance costs and the pointless utilization of healing facility assets, this review audits the adequacy of submitting breast capsulectomy examples for pathological examination.

Prevention of cancer recurrence is the top priority when it comes to breast cancer surgery. The goal is to remove the tumor so that it won't reappear later in your breast, or spread to and appear in other parts of your body. Before having the surgery for breast cancer, taking some time to learn about the different types of procedures is must.

  • Track 13-1Simple or Total Mastectomy
  • Track 13-2Modified Radical Mastectomy
  • Track 13-3Radical Mastectomy
  • Track 13-4Skin-Sparing Mastectomy
  • Track 13-5Lumpectomy (Partial Mastectomy)

Mastectomy is the removal of the whole breast. It's used to treat breast cancer in women and  in men. There are five different types of mastectomy: "simple" or "total" mastectomy modified radical mastectomy, radical mastectomy, partial mastectomy, and subcutaneous (nipple-sparing) mastectomy.



  • Track 14-1Radical Mastectomy
  • Track 14-2Pathology Mastectomy
  • Track 14-3Breast Reconstruction
  • Track 14-4Nipple-sparing mastectomy

A prognosis is the doctor’s best estimate of how cancer will affect someone and how it will respond to treatment. Prognosis and survival depend on many factors. Only a doctor familiar with your medical history, the type, stage and characteristics of your cancer, the treatments chosen and the response to treatment can put all of this information together with survival statistics to arrive at a prognosis. A prognostic factor is an aspect of the cancer or a characteristic of the person that the doctor will consider when making a prognosis. A predictive factor influences how a cancer will respond to a certain treatment. Prognostic and predictive factors are often discussed together. They both play a part in deciding on a treatment plan and a prognosis. Doctors use different prognostic and predictive factors for newly diagnosed and recurrent breast cancers.

At least one in nine women develops breast cancer at some stage in their life. About 48,000 cases occur in the United Kingdom every year. Mostly develops in women over the age of 50 but younger women are also sometimes affected. Breast cancer can also develop in men, but this is rare. Breast cancer develops from a cancerous cell which develops in the lining of a mammary duct or a lobule in one of the breasts. It follows the classic progression though it often becomes systemic or widespread in the early onset of the disease. In 2012, the latest year for which information is accessible, in excess of 1.7 million ladies worldwide were determined to have Breast Cancer.

Pregnancy-associated breast cancer is defined as breast cancer diagnosed during pregnancy or in the first postpartum year.  Breast cancer affects approximately 1 in 3000 pregnant women and is the second most common malignancy affecting pregnancy. The average age of women with Pregnancy-associated breast cancer is 32 to 38 years.  Only 6.5% of all cases of breast cancer affect women age < 40 years.  As more women are delaying childbearing, and as breast cancer rates continue to raise, more diagnoses of Pregnancy-associated breast cancer are anticipated. However, because Pregnancy-associated breast cancer is a relatively rare event surrounded by multiple variables, few studies address the best management and treatment options.


Tubular carcinoma of the breast is a subtype of invasive ductal carcinoma (cancer that begins inside the breast's milk duct and spreads beyond it into healthy tissue). Tubular carcinomas are usually small (about 1 cm or less) and made up of tube-shaped structures called "tubules." These tumors tend to be low-grade, meaning that their cells look somewhat similar to normal, healthy cells and tend to grow slowly.

Male breast cancer is a disease in which malignant (cancer) cells form in the tissues of the breast. Most male breast cancer begins in cells lining the ducts. It is very rare and usually affects older men.

A biomarker is a substance in a person’s blood, urine, or other body fluids. It can also be found in or on the tumor. A biomarker, sometimes called a tumor marker, is made by the tumor or by the body in response to the cancer. Biomarkers help doctors learn more about each person’s cancer so they can recommend the best treatment options for each patient. The success of breast cancer therapy is ultimately defined by clinical endpoints such as survival. It is valuable to have biomarkers that can predict the most efficacious therapies or measure response to therapy early in the course of treatment. Molecular imaging has a promising role in complementing and overcoming some of the limitations of traditional biomarkers by providing the ability to perform noninvasive, repeatable whole-body assessments.